In a late evening filing, RIL said that it will also get a 100% direct equity ownership of Netmeds’ subsidiaries, Tresara Health, Netmeds Market Place and Dadha Pharma Distribution.
PharmEasy, Medlife merger
Meanwhile, online medical store PharmEasy has agreed to merge with smaller rival Medlife, filings with India’s antitrust body show. The move heralds the first big consolidation play in a sector that has seen heightened competition and entry of deep-pocketed players like Reliance Industries and Amazon.
Medlife will sell 100% shares to API Holdings, the parent entity of PharmEasy, in return for 19.59% ownership in the combined entity, according to the filing with the Competition Commission of India (CCI). Both firms have formally requested CCI to approve the proposed merger.
ET has reviewed a copy of the filing. Sources in the know of the deal details pegged the valuation of the combined entity at $1.2 billion, which values the stake of Medlife shareholders at around $235 million. PharmEasy was valued at around $700 million when it closed a $220 million funding round led by Singapore’s Temasek in November. It is as yet unclear if the transaction is a purely stock-swap deal. PharmEasy and Medlife did not respond to ET’s queries till press time Tuesday.
ET reported on August 4 that India’s online pharmacy space is expected to see a wave of consolidation, triggered by Reliance Industries’ reported acquisition of Chennai-based Netmeds.
Mumbai-based PharmEasy – backed by Temasek, CDPQ and Orios Venture Partners – is looking to line up financial investors, including US private equity firm TPG – which has a strong healthcare focused portfolio, to invest in the combined entity.
“The proposed combination relates to the acquisition of 100% equity shares of Medlife by API Holdings, and as consideration, the acquisition of up to 19.59% of the equity share capital of API Holdings (on a fully diluted basis), by the Medlife Promoter Shareholders and other shareholders of Medlife,” the filing read.
Medlife was founded by Tushar Kumar, son of Alkem Laboratories owners Prabhat Narain Singh and Prashant Singh, Ananth Narayanan, who was appointed Medlife CEO in August last year, will stay on as an advisor for some time even after the deal is closed, sources added.
Read More News on
ETPrime stories of the day
10 mins read
18 mins read
13 mins read
- MoviePass Parent’s Stock Up 40% (To Above A Penny) After Latest Strategy Tweak
- Fox RSN auction hits 1st-round snag as MLB presses bankers on digital rights pitch
- How Canopy Growth became the Jolly Green Giant of cannabis
- Competing Against Chinese Loans, U.S. Companies Face Long Odds
- Competing Against Chinese Loans, U.S. Companies Face Long Odds in Africa
- Genoa Bridge Collapse Throws Harsh Light on Benettons’ Highway Billions
- This Billionaire's 'Terrible Purchase' Just Made $14 Billion In Profits, And Now He's Ready For More
- The hottest new wellness startups are selling houseplants
- Waiting for his time to come: WKU's Taywan Taylor prepares for NFL call
- Juul now has '800-pound gorilla' to fight FDA, experts warn
- From Kylie Jenner To Daniel Ek, The 10 Most Notable New Billionaires Of 2019
- Peugeot Returns to U.S. to Help People Get Around, but Not With Its Cars
Reliance retail acquires majority stake in Netmeds' parent for Rs 620 crore have 675 words, post on economictimes.indiatimes.com at August 19, 2020. This is cached page on Talk Vietnam. If you want remove this page, please contact us.